Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders

Authors
Byrd, JC Grever, MR Waselenko, JK Willis, CR Park, K Goodrich, A Lucas, MA Shinn, C Flinn, IW
Citation
Jc. Byrd et al., Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders, SEMIN ONCOL, 27(2), 2000, pp. 37-40
Citations number
10
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
SEMINARS IN ONCOLOGY
ISSN journal
00937754 → ACNP
Volume
27
Issue
2
Year of publication
2000
Supplement
5
Pages
37 - 40
Database
ISI
SICI code
0093-7754(200004)27:2<37:TP(ACA>2.0.ZU;2-H